首页|老年慢性阻塞性肺疾病患者衰弱发生情况及其影响因素分析

老年慢性阻塞性肺疾病患者衰弱发生情况及其影响因素分析

扫码查看
目的 调查老年慢性阻塞性肺疾病患者衰弱发生情况,并对衰弱发生的影响因素进行分析.方法 收集230例老年慢性阻塞性肺疾病患者的临床资料,并进行衰弱评估,统计衰弱发生情况;对发生衰弱与未发生衰弱患者的临床资料进行比较分析,了解影响衰弱发生的影响因素.结果 230例老年慢性阻塞性肺疾病患者发生衰弱43例,发生率为18.70%.发生衰弱与未发生衰弱患者的性别、吸烟史、饮酒史、体质量指数(BMI)、白细胞计数(WBC)、中性粒细胞计数(NEUT)比较,无明显差异(P>0.05);发生衰弱患者年龄、居住状态、疾病严重程度、合并症、疾病接受度、抑郁状态、多重用药、血红蛋白(Hb)、白细胞介素-6(IL-6)与未发生衰弱患者比较存在明显差异(P<0.05).以衰弱为因变量(非衰弱=0,衰弱=1),分别对年龄(<75岁=0,≥75岁=1)、居住状态(非独居=0,独居=1)、病情严重程度(轻中度=0,重度及以上=1)、合并症(无=0,有=1)、疾病接受度(良好或完全接受=0,差或不能接受=1)、抑郁状态(否=0,是=1)、多重用药(否=0,是=1)、IL-6(<3 ng/L=0,≥3 ng/L=1)、Hb(≥115 g/L=0,<115 g/L=1)等自变量进行赋值,纳入多因素Logistic回归分析.多因素Logistic回归分析显示,年龄≥75岁[OR=2.199,95%CI=(1.098,4.405)]、疾病严重程度重度及以上[OR=2.478,95%CI=(1.244,4.938)]、存在合并症[OR=5.583,95%CI=(2.157,14.450)]、疾病接受度差或不能接受[OR=7.438,95%CI=(2.259,24.487)]、抑郁状态[OR=5.109,95%CI=(2.017,12.942)]、多重用药[OR=3.415,95%CI=(1.422,8.203)]、IL-6≥3 ng/L[OR=1.283,95%CI=(1.098,1.499)]是老年慢性阻塞性肺疾病患者发生衰弱的危险因素,Hb≥115 g/L[OR=0.556,95%CI=(0.312,0.991)]是老年慢性阻塞性肺疾病患者发生衰弱的保护因素(P<0.05).结论 老年慢性阻塞性肺疾病患者衰弱发生率较高,导致其发生衰弱的因素多,临床应积极对患者具体情况进行评估,针对高危人群予以针对性干预,以帮助患者预防和控制衰弱的发生.
Analysis of the incidence of frailty and its influencing factors in elderly patients with chronic obstructive pulmonary disease
Objective To investigate the occurrence of frailty in elderly patients with chronic obstructive pulmonary disease and analyze the influencing factors for frailty. Methods The clinical data of 230 elderly patients with chronic obstructive pulmonary disease were collected and assessed for frailty,and the occurrence of frailty was counted. Comparative analysis of clinical data between patients with and without frailty to understand the factors affecting frailty occurrence. Results 34 of 230 patients experienced frailty,with an incidence rate of 18.70%. There were no significant differences in gender,smoking history,drinking history,body mass index (BMI),white blood cell count (WBC),neutrophil count (NEUT) between patients with and without frailty (P>0.05). There were significant differences in age,residential status,disease severity,comorbidities,disease acceptance,depressive state,multiple drug use,hemoglobin (Hb),interleukin-6 (IL-6) between patients with and without frailty (P<0.05). With frailty as the dependent variable (non-frailty=0,frailty=1),age (<75 years=0,≥75 years=1),residential status (non-living alone=0,living alone=1),disease severity (mild to moderate=0,severe or above=1),comorbidities (no=0,yes=1),disease acceptance (good or complete acceptance=0,poor or unacceptable=1),depressive status (no=0,yes=1),multiple drug use (no=0,yes=1),IL-6 (<3 ng/L=0,≥3 ng/L=1),and Hb (≥115 g/L=0,<115 g/L=1) were assigned values for the independent variables and included in multifactorial Logistic regression analysis. Multivariate Logistic regression analysis showed that age ≥75 years old[OR=2.199,95%CI=(1.098,4.405)],severe or above disease severity[OR=2.478,95%CI=(1.244,4.938)],comorbidities[OR=5.583,95%CI=(2.157,14.450)],poor disease acceptance or unacceptable[OR=7.438,95%CI=(2.259,24.487)],depressive state[OR=5.109,95%CI=(2.017,12.942)],multiple drug use[OR=3.415,95%CI=(1.422,8.203)],IL-6≥3 ng/L[OR=1.283,95%CI=(1.098,1.499)]were risk factors for frailty in elderly patients with chronic obstructive pulmonary disease. Hb≥115 g/L[OR=0.556,95%CI=(0.312,0.991)]was a protective factor for frailty in elderly patients with chronic obstructive pulmonary disease (P<0.05). Conclusion The incidence of frailty in elderly patients with chronic obstructive pulmonary disease is relatively high,and there are many factors that lead to frailty. Clinical evaluation of patients should be actively carried out,and targeted interventions should be given to high-risk populations to help patients prevent and control frailty.

Chronic obstructive pulmonary diseaseFrailtyInfluencing factorsOld age

蒙华

展开 >

832002 石河子市人民医院老年医学科

慢性阻塞性肺疾病 衰弱 影响因素 老年

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(23)